|
|||||
|
|
A potential risk factor for paraoxonase 1: in silico and in‐vitro analysis of the biological activity of proton‐pump inhibitors |
|
| Authors: | Cü neyt Tü rke |
| Affiliation: | Cüneyt Türkeş |
| Abstract: | |
| Keywords: | coronary artery diseases HDL inhibition molecular docking paraoxonase proton‐pump inhibitor |